Moreover, combined panel of let-7f-5p and PSA could discriminate PCa patients from BPH subjects with higher performance than PSA alone, suggesting this panel can improve the diagnostic route of PSA testing. Here, KLK3 is linked to benign prostatic hyperplasia.